Abbvie的研发网站开创性创新

AbbVie is headquartered in North Chicago, IL. Here, we take on some of the world's most complex diseases, focusing on immunology, oncology and neuroscience. Our headquarters covers the full spectrum of research and development from the initial idea to the finished product.
\r\n
\r\nOur headquarters is also home to our drug discovery engine, which drives our existing and novel therapeutic platforms, and our Genomics Research Center, which translates genetic information into a more personalized approach to medicines. It’s also home to other areas of expertise, including regulatory affairs, patient safety, manufacturing, process chemistry, solid state chemistry, process engineering, medical affairs, and quality assurance.

\r\n"}}" id="text-39c57bf2f6" class="cmp-text">

Abbvie总部位于伊利诺伊州北芝加哥。在这里，我们采用了一些世界上一些最复杂的疾病，重点是免疫学，肿瘤学和神经科学。我们的总部涵盖了从最初的想法到成品的全部研发。狗万正网地址

我们的总部也是我们的药物发现引擎的所在地，该引擎驱动了我们现有和新颖的治疗平台，以及我们的基因组研究中心，该中心将遗传信息转化为一种更个性化的药物方法。它也是其他专业知识领域的所在地，包括监管事务，患者安全，制造，过程化学，固态化学，过程工程，医疗事务和质量保证。

Our Irvine site is home to our Center of Excellence for aesthetics, neurotoxins, neuro-psychiatry, migraine and eye care research. The 54-acre, 1,000,000-square-foot campus offers unique scientific expertise in the research and development of translational and pharmaceutical sciences to deliver patient-centric, innovative medicines.

\r\n"}}" id="text-b3be4a9768" class="cmp-text">

我们的欧文网站是我们美学，神经毒素，神经精神病学，偏头痛和眼保健研究的卓越中心的所在地。这座占地54英亩的1,000,000平方英尺的校园在转化和制药科学的研究和开发方面提供了独特的科学专业知识，以提供以患者为中心的创新药物。狗万正网地址

The latest addition to our R&D locations, our Bay Area site is the epicenter of our cutting-edge work to advance oncology research. Here, we're evaluating a range of investigational medicines as potential treatments for various types of cancer and accelerating our R&D pipeline in immuno-oncology, tumor targeting, tumor dependencies and precision medicine. AbbVie Bay Area is also home to other functions including data statistics and analytics, medical affairs, patient safety, quality assurance and regulatory affairs.
\r\n
\r\nThis new 48,000-square-foot campus, located in the birthplace of biotech, opens doors to new partnerships and collaboration to advance the next breakthroughs.

\r\n"}}" id="text-a59b92f222" class="cmp-text">

我们的研发地点的最新成员是我们的湾区地点是我们促进肿瘤研究的尖端工作的中心。在这里，我们正在评估一系列研究药物作为各种癌症的潜在治疗方法，并加速了我们在免疫肿瘤，肿瘤靶向，肿瘤依赖性和精密医学方面的研发管道。Abbvie Bay地区也是其他功能的所在地，包括数据统计和分析，医疗事务，患者安全，质量保证和监管事务。

这个新的48,000平方英尺的校园位于Biotech的出生地，为新的合作伙伴关系打开了大门，并合作推动了下一个突破。

AbbVie's Cambridge Research Center is a 43,000-square-foot facility located in the Cambridge, Massachusetts biotech corridor. Inside this research center, our scientists are focused on understanding the biological mechanisms underlying neurodegenerative diseases, in particular, Alzheimer's and Parkinson's diseases, as well as immune-mediated diseases.

\r\n"}}" id="text-cd583257c6" class="cmp-text">

Abbvie's Cambridge Research Center是一个43,000平方英尺的设施，位于马萨诸塞州剑桥市生物技术走廊。在该研究中心内，我们的科学家专注于了解神经退行性疾病的生物学机制，特别是阿尔茨海默氏症和帕金森氏病，以及免疫介导的疾病。

For over 30 years, the AbbVie Bioresearch Center in Worcester, Massachusetts, has been an industry leader in drug discovery, development sciences and biologics research. This 553,000-square-foot facility focuses on biotherapeutics development and explores innovative solutions for some of the toughest challenges in medicine, including immunology and neuroscience.

\r\n"}}" id="text-f9c86dfaf5" class="cmp-text">

30多年来，马萨诸塞州伍斯特的Abbvie Bioresearch中心一直是药物发现，开发科学和生物学研究的行业领导者。狗万正网地址这个553,000平方英尺的设施着重于生物治疗学开发，并探讨了包括免疫学和神经科学在内的一些最艰巨挑战的创新解决方案。狗万正网地址

At our integrated facility in Ludwigshafen, Germany, we carry out every step of drug research, development and production. Here, scientists look for ways to treat neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease and pioneer new methods of formulating complex compounds to make better medicines possible.
\r\n
\r\nLudwigshafen also contributes to the digitalization of research by utilizing artificial intelligence, machine learning, bioinformatics and other technologies that enable preclinical and clinical studies worldwide.

\r\n"}}" id="text-acd625e0bb" class="cmp-text">

在我们在德国路德维希芬（Ludwigshafen）的综合设施中，我们执行了药物研究，开发和生产的每一步。狗万正网地址在这里，科学家正在寻找治疗神经退行性疾病的方法，例如阿尔茨海默氏病，帕金森氏病和先驱者制定复合化合物以使更好的药物成为可能。

路德维希芬（Ludwigshafen）还利用人工智能，机器学习，生物信息学和其他能够在全球范围内促临床研究和临床研究来促进研究的数字化。

AbbVie's Tokyo R&D site is home to our full clinical development capabilities. To obtain NDA approvals for AbbVie's products for Japanese patients, we conduct studies in parallel from phase 1 to phase 4. We perform strategic clinical planning functions for each focus area to develop the Japan-specific development strategy across oncology, immunology, neuroscience, specialty, eye care and aesthetics.

\r\n"}}" id="text-2958661638" class="cmp-text">

Abbvie的东京研发网站是我们完整的临床开发能力的所在地。狗万正网地址为了获得日本患者Abbvie产品的NDA批准，我们从第1阶段到第4阶段并行进行研究。我们为每个焦点区域执行战略性的临床计划功能，以制定跨肿瘤学，免疫学，神经科学，专业，专业，专业，专业，专业，专业，专业的发展策略狗万正网地址眼保健和美学。